Literature DB >> 21057696

High incidence of ankle arthropathy in mild and moderate haemophilia A.

Min Ling1, Jonathan Peter Hans Heysen, Elizabeth Mary Duncan, Susan Elizabeth Rodgers, John Viner Lloyd.   

Abstract

A clinical study of patients with mild haemophilia A to document the frequency and severity of arthropathy has not been previously published. We studied ankle arthropathy in 34 patients with mild/moderate haemophilia A. The patients were assessed for the presence and severity of pain, and by the physical and radiological scoring systems for the evaluation of haemophilic arthropathy recommended by the World Federation of Haemophilia (WFH). Of the 34 patients, 16 (47%) had ankle pain, which was of moderate to severe degree in nine patients, and associated with limitation of physical activities in 13 patients. Of 33 patients examined by radiology 17 (52%) were positive for ankle arthropathy, and of these, 16 were also positive by the physical score. The presence and severity of ankle arthropathy was more common in patients with a one-stage factor VIII level of less than or equal to 11 IU/dl. There was a significant relationship between the presence of ankle arthropathy and a history of bleeds into the ankle joint as a child. We conclude that arthropathy of the ankle in these patients is common, is often severe and disabling, and is due to episodes of bleeding into the ankle joint during childhood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057696     DOI: 10.1160/TH10-07-0492

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study.

Authors:  Karin P M van Galen; Piet de Kleijn; Wouter Foppen; Jeroen Eikenboom; Karina Meijer; Roger E G Schutgens; Kathelijn Fischer; Marjon H Cnossen; Joke de Meris; Karin Fijnvandraat; Johanna G van der Bom; Britta A P Laros-van Gorkom; Frank W G Leebeek; Eveline P Mauser-Bunschoten
Journal:  Haematologica       Date:  2017-06-01       Impact factor: 9.941

2.  Joint status of patients with nonsevere hemophilia A.

Authors:  Anne-Fleur Zwagemaker; Fabienne R Kloosterman; Robert Hemke; Samantha C Gouw; Michiel Coppens; Lorenzo G R Romano; Marieke J H A Kruip; Marjon H Cnossen; Frank W G Leebeek; Barbara A Hutten; Mario Maas; Karin Fijnvandraat
Journal:  J Thromb Haemost       Date:  2022-03-07       Impact factor: 16.036

3.  Infrared Thermography as a Non-Invasive Tool to Explore Differences in the Musculoskeletal System of Children with Hemophilia Compared to an Age-Matched Healthy Group.

Authors:  Axel Seuser; Karin Kurnik; Anne-Katrin Mahlein
Journal:  Sensors (Basel)       Date:  2018-02-08       Impact factor: 3.576

4.  A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A.

Authors:  Koichiro Yoneyama; Christophe Schmitt; Naoki Kotani; Gallia G Levy; Ryu Kasai; Satofumi Iida; Midori Shima; Takehiko Kawanishi
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.